20.03.2018 • News

CIA and Cefic Urge UK-EU Partnerships post-Brexit

CIA and Cefic Urge UK-EU Partnerships post-Brexit (c) lazyllama/Shutterstock
CIA and Cefic Urge UK-EU Partnerships post-Brexit (c) lazyllama/Shutterstock

As the UK agrees terms with the EU on Brexit’s transition period, the Chemical Industries Association (CIA) has welcomed the confirmation that access to each other’s markets will remain unchanged until Dec. 31 2020, something the organization said it has been campaigning for.

CIA chief executive Steve Elliott said that he hoped UK Prime Minister Theresa May’s proposal of associate membership of the European Chemicals Agency (ECHA) could now be given serious consideration in the detailed negotiations to follow.

His comments come just three days after the CIA and the European Chemical Industry Council (Cefic) issued a joint statement, voicing their "considerable concern” over the EU’s failure to include any mention of associate membership of EU agencies, including ECHA, when it issued draft guidelines on negotiations with the UK on Mar 7.

The organizations said that a continued partnership between the UK and ECHA would avoid duplicate testing and related costs under REACH legislation, along with assuring continuity of supply to key industries such as aerospace, automotive and pharmaceuticals.  Establishing a separate UK agency would take years to achieve, they said, and, at significant cost, threaten to waste a decade’s worth of investment into chemical safety by government and industry.

Separately, Cefic has linked with the European Chemical Employers Group (ECEG), which represents the chemical, pharmaceutical, rubber and plastics industries, and industriAll European Trade Union, to stress the importance of a post-Brexit relationship that would avoid adverse effects on the industry’s viability, international competitiveness and employment on both sides of the Channel.

Among other things, the associations are calling for an appropriate transition period with pragmatic and workable arrangements on legal jurisdiction and dispute resolution; a comprehensive and smooth trade relationship that enables the easy flow of goods and free movement of employees; and regulatory consistency.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.